Clinical
Double-Blind
A trial design in which neither participants nor researchers know who receives drug vs placebo.
Definition
Double-blinding prevents expectation bias from affecting outcome measurement. It is considered standard for Phase 2 and Phase 3 trials of most interventions.
Related terms
Back to the full peptide glossary.